Did you miss GVK BIO’s recent webinar on Targeted protein degradation in inflammation and cancer therapy. You can access the following by filling this quick form:

  • Webinar recording video
  • Q&A transcript of live session

This webinar will focus on our efforts with PROTACs in the areas of inflammation and cancer. Specifically, speakers has discussed challenges and opportunities for developing PROTACs in the areas of autoimmune and inflammatory diseases driven by IL-1R/TLR1 signaling and inflammasome activation and in potentially undruggable epigenetic pathways that involve bromodomain proteins, histone acetyltransferases and deacetylases.

During this session, participants will learn:

  • PROTAC technology and challenges in the field
  • Opportunities and strategies for developing PROTACs in cancer and inflammation
  • Screening PROTACs: available tools and assays for mechanistic profiling
  • DMPK optimization for oral bioavailability

Duration - 1hour
Featured Speakers


Amar Thyagarajan, Ph.D.,
Global Strategy Head and Head of NA BD
GVK Biosciences and Aragen Biosciences
Venkatesh Babu Jayaraman, Principal Scientific Manager
GVK Biosciences